DLDon H. Le

Don H. Le

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Don H. Le has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Contemporary Concepts in Cervical Disk Arthroplasty: Implant Design, Constraint, Complications, and Technical Pearls

    by Austin Q. Nguyen, Andrei Demkov, Don Le, Rohan Vemu, Mark L. Prasarn, Corey T. Walker, Hyun W. Bae, Todd Albert, Andrew A. Sama, Sheeraz A. Qureshi, et al.

    » Cervical disk arthroplasty (CDA) is a Food and Drug Administration (FDA)–approved motion-preserving alternative to anterior cervical diskectomy and fusion for 1-level and 2-level degenerative disk diseases, supported by high-level evidence and associated with reduced adjacent segment degeneration and comparable or improved clinical outcomes. » FDA-approved CDA implants differ in biomechanical design, degrees of freedom (DoF), and constraint, affecting motion preservation, segmental control, and long-term kinematics. Devices range from constrained (3 DoF) to semiconstrained and viscoelastic designs (4-6 DoF). Implant articulation and materials impact wear, imaging compatibility, and biomechanical behavior and should be considered during device selection. » Constraint-based classification provides a practical, biomechanics-informed framework for CDA implant selection. Constraint level should be matched to patient pathology. Constrained implants may be preferable in cases of segmental instability, compromised endplate integrity, or poor bone quality. Semiconstrained or viscoelastic devices may offer better outcomes for patients with preserved motion, healthy facets, and high functional demands. » A structured understanding of failure modes is critical for safe and effective CDA use. Complications and failure can result from surgical technique errors (e.g., endplate violation, malposition), biologic response (e.g., osteolysis, heterotopic ossification), or mechanical complications (e.g., implant fracture, subsidence). Technical considerations aid the surgeon in reducing risk of complications.


  • Open Access

    Common Serum Biomarkers and Combination Ratios in the Diagnosis of Periprosthetic Joint Infection Following Total Hip Arthroplasty

    by Jason M. Dayan, Don H. Le, Anzar Sarfraz, Theodor Di Pauli von Treuheim, Farouk Khury, Sallie Yassin, Vinay K. Aggarwal, Ran Schwarzkopf, Alan J. Dayan

    Accurate preoperative diagnosis of periprosthetic joint infection (PJI) is difficult, complicating distinction between septic and aseptic failures. This study assessed the value of common serum biomarkers and three calculated ratios—albumin–globulin ratio (AGR), C-reactive protein–albumin ratio (CAR), and C-reactive protein–AGR ratio (CAGR)—in diagnosing PJI after primary total hip arthroplasty (THA). We retrospectively reviewed patients undergoing revision THA for PJI or aseptic failure from 2011 to 2021 at a single institution. Inclusion required reported serum white blood cell count (WBC), C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), albumin (Alb), and total protein (TP). Diagnostic performance was evaluated using areas under the curve (AUCs), with higher values indicating better accuracy. Ratios were defined as: AGR = Alb/[TP − Alb], CAR = CRP/Alb, and CAGR = CRP/AGR. Among 128 cases, 67 were PJI and 61 aseptic. AUCs were: WBC (0.53), CRP (0.69), ESR (0.75), Alb (0.69), Glb (0.63), TP (0.53), AGR (0.72), CAR (0.70), and CAGR (0.71). Optimal cutoff, sensitivity, and specificity were: CRP (10.5, 0.76, 0.59), ESR (41.0, 0.70, 0.72), AGR (1.10, 0.64, 0.75), CAR (3.37, 0.73, 0.64), and CAGR (10.9, 0.75, 0.66). ESR, AGR, CAR, and CAGR demonstrated acceptable accuracy. These readily available markers and ratios may aid PJI diagnosis, supporting improved clinical decision-making.